Last reviewed · How we verify
NCT06864286
Nationwide Multi-dimensional Health Promotion Program for Community-Dwelling Older Adults
NA trial testing Move for Health in Community-dwelling Older Adults in 270 participants. Not yet recruiting.
31 December 2025
Quick facts
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 270 |
| Start date | 1 March 2025 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2026 |
Drugs / interventions tested
- Move for Health
Conditions studied
- Community-dwelling Older Adults — all drugs for Community-dwelling Older Adults →
Sponsor
National Taiwan University Hospital
Who can join
25 and older, any sex, with Community-dwelling Older Adults. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Global organizations advocate for "active" and "healthy aging," emphasizing preventive health promotion. Taiwan's Long-Term Care 2.0 and the National Health Administration's "Healthy Exercise Class" exemplify this. Evaluating these programs' effectiveness is crucial, but complex due to diverse influencing factors. This study focuses on the often-overlooked role of program leaders' facilitation skills in impacting program success. This study investigates the effectiveness of multi-domain community health promotion programs for older adults and its influencing factors. Specifically, it aims to: 1. assess the immediate benefits (objective/subjective health status, satisfaction) for participating older adults. 2. explore related factors (group leadership skills, personal factors) using Andersen's Behavioral Model. A prospective, single-group, pre- and post-test design will be used. Participants (leaders and older adults) will be recruited from "Healthy Exercise Class" sites nationwide. Pre- and post-intervention data will be analyzed to determine program effectiveness. Multiple linear regression will identify influencing factors, including the mediating and moderating effects of leader facilitation skill confidence. The study aims to inform policy improvements for government-led older adult health promotion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06864286
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other National Taiwan University Hospital trials
Trials by the same sponsor.
- NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
- NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
- NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
- NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06864286 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
- Last refreshed: 7 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06864286.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing